Theravance Biopharma (TBPH) Net Equity Issued and Repurchased (2015 - 2025)
Theravance Biopharma (TBPH) posted quarterly Net Equity Issued and Repurchased of $20000.0 for Q1 2025, down 33.33% quarter-over-quarter from $30000.0 in Q4 2024.
Powered by 
Analysis
Theravance Biopharma (TBPH) Net Equity Issued and Repurchased (2015 - 2025) Analysis & Trends
Theravance Biopharma (TBPH) has reported Net Equity Issued and Repurchased for 5 consecutive years, with $20000.0 the latest figure, recorded in Q1 2025.
- In Q1 2025, Net Equity Issued and Repurchased changed N/A year-over-year to $20000.0; the TTM figure through Dec 2025 stood at $20000.0 (down 63.64% YoY), while the FY2025 annual figure was $20000.0, down 79.8% from the prior year.
- Net Equity Issued and Repurchased declined to $20000.0 in Q1 2025 per TBPH's latest filing, from $30000.0 in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $30000.0 in Q4 2024 and bottomed at $20000.0 in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 141.90 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Theravance Biopharma | 882.99 Mn | 495.33 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 20,000.00 |
| Dec 31, 2024 | 30,000.00 |
| Sep 30, 2024 | 25,000.00 |
| Mar 31, 2020 | 139.92 Mn |
| Dec 31, 2016 | 107.79 Mn |
| Sep 30, 2016 | 17,000.00 |
| Jun 30, 2016 | 117.42 Mn |
| Mar 31, 2016 | 27.80 Mn |
| Dec 31, 2015 | 51.76 Mn |
| Sep 30, 2015 | -48,000.00 |
| Jun 30, 2015 | 1.56 Mn |
| Mar 31, 2015 | 25.75 Mn |